FREE CONSULTATION 24/7   800.404.9281  504.286.2022 
Van Robichaux
Trial Attorney
Renee Robichaux
Attorney At Law
Sharon Kirkey - CanWest News Service

Monday, April 17, 2006

Health Canada is investigating reports of strokes and heart attacks in people taking Accutane, the controversial acne drug that causes birth defects and has been linked with psychiatric problems.

Free Accutane Case EvaluationTwenty-nine cases of patients who developed a vascular disorder after taking isotretinoin, the generic name for Accutane, have been reported since the drug was approved in Canada in 1983.

Eleven involved strokes, blood clots or a heart attack, none of which are labelled as possible reactions in the drug's prescribing information. The patients ranged in age from 15 to 48.

One 18-year-old with no known risk factors suffered a stroke two months after starting the drug.

"Health-care professionals are encouraged to report any cases of myocardial infarction, cerebrovascular and thromboembolic disorders suspected of being associated with isotretinoin," a new Health Canada report on adverse drug reactions says.

Canadian retail pharmacies filled 224,515 prescriptions for Accutane last year, worth $33.8 million, according to IMS Health Canada. Isotretinoin's use is expected to grow as cheaper generic versions reach the market.

Beginning in December 2005, new regulations will require doctors and patients to register in an electronic database before the drug can be dispensed. The plan also includes two pregnancy tests, two birth control methods and other previously recommended safeguards.

On August 12th the FDA announced that starting December 31, 2005, thousands of Accutane users, plus the doctors who prescribe it and stores that sell it, must enroll in a national registry that ensures they understand all the drug’s risks, and take special steps to avoid the most notorious one, Accutane-damaged pregnancies.

If a woman becomes pregnant while taking the acne drug, her baby can suffer severe brain and heart defects, mental retardation and other abnormalities. The drug may also trigger or worsen depression or suicidal thoughts, according to a warning on the pills’ label that the FDA strengthened Friday and that patients are to receive as part of the new program.

 

Free Case Evaluation

General Information
First Name
Last Name
City
Zip Code
State
Country
Primary Phone
Alternate Phone
E-Mail Address
Accutane Use
Date you last used Accutane:
Medications Used
Accutane
Generic Accutane : Amnesteem, Claravis, and/or Sotret.
Diagnosis
Inflammatory Bowel Disease
Ulcerative Colitis
Crohn's Disease
Other (Please Explain)
Approximately what year was the diagnosis by a medical professional?
Please describe the nature and extent of your injuries resulting from your use of Accutane:
Questions / Comments
 
I have read and understand the Terms & Conditions Below.

Send Request
Terms & Conditions
Please be advised we do not and cannot represent you until we have had an opportunity to evaluate your potential claim. Until such time as we have a signed contract of representation from you, we do not represent you in any claim Be advised that the statute of limitations on your claim may have already expired and, if it has not, each day that passes brings you closer to the expiration of the statute of limitations. Thus, you need to act immediately in filling out the above questionnaire. We do not represent you until we have received a fully executed fee agreement.

Thank You! Thank you for your recent inquiry. I, or a member of my staff will contact you by e-mail or telephone to obtain further details.

We will call or email you in the next 30 minutes to discuss your case.

Sorry, There was a problem sending your request. Click the button above to send me an email at info@robichauxlaw.com. I, or a member of my staff will contact you by e-mail or telephone to obtain further details of your Accutane ingestion.



6001 Stars and Stripes Blvd.
Suite 230
New Orleans, LA 70126
Lakefront Airport
800.404.9281
504.286.2022 info@robichauxlaw.com
Google Plus Yelp Avvo Linked In Facebook Twitter Email